Travere Therapeutics (TVTX) PT Raised to $60 at TD Cowen

May 5, 2026 8:54 AM

TD Cowen analyst Tyler Van Buren raised the price target on Travere Therapeutics (NASDAQ: TVTX) to $60.00 (from $45.00) while maintaining a Buy rating.

No results found